Next Article in Journal
Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial
Previous Article in Journal
Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 3
10.3390/cancers17030436
Version Notes
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Review

Article Versions Notes

Cancers 2025, 17(3), 436; https://doi.org/10.3390/cancers17030436
Action Date Notes Link
article pdf uploaded. 27 January 2025 16:30 CET Version of Record https://www.mdpi.com/2072-6694/17/3/436/pdf-vor
article xml file uploaded 7 February 2025 07:58 CET Original file -
article xml uploaded. 7 February 2025 07:58 CET Update https://www.mdpi.com/2072-6694/17/3/436/xml
article pdf uploaded. 7 February 2025 07:58 CET Updated version of record https://www.mdpi.com/2072-6694/17/3/436/pdf
article html file updated 7 February 2025 08:01 CET Original file -
article html file updated 24 June 2025 14:18 CEST Update https://www.mdpi.com/2072-6694/17/3/436/html
Back to TopTop